TransProtein is an independently developed graphical AI protein design platform that integrates core algorithms such as GPDL backbone design, GPD sequence generation, and IDPFold dynamic structure prediction, covering de novo design and targeted modification of peptide drugs, antigens and antibodies, and industrial enzymes. The platform supports graphical drag-and-drop operation and one-click automated workflows, allowing users to complete the entire virtual screening process from structure generation and sequence design to functional prediction without writing code. It is also compatible with mainstream international methods such as ESMFold, providing flexible, efficient, and scalable protein engineering solutions for R&D teams with varying experience levels.

Relying on its self-developed algorithm matrix, the platform can complete the design and virtual screening of tens of thousands of sequences in about two weeks, reducing the preclinical development cycle of protein drugs from the traditional four years to 12–18 months.